Aditi Shastri, Associate Professor at Albert Einstein College of Medicine, shared a post on LinkedIn:
“I am super stoked to share a new paper from shastrilab titled “A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia” published in Leukemia, Nature Portfolio. Many congratulations to first author Samarpana Chakraborty! Many thanks to several excellent collaborators that contributed to this work, notably Prof Keisuke Ito (Einstein), Sergei Koralov, Steven Kornblau. A special thanks to a crucial partner Kymera Therapeutics. It takes a village to do translational science that plugs critical unmet clinical needs.”